Allergan introduces hybrid injectable
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
Global pharmaceutical company Allergan Aesthetics has launched HArmonyCa to the UK market, a hybrid injectable treatment combining hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).
Pharmaceutical company Galderma has launched hyaluronic acid filler Restylane Eyelight to the UK.
Dr Euan Mackinnon explores if we can achieve surgical outcomes using a non-surgical approach
Canadian dermal filler range Revanesse has released new training dates.
Dr Jasmin Taher discusses her experience with VIVACY’s latest lip filler
Pharmaceutical company Galderma is developing a new bio-stimulating filler based on silk technology.
The Medicines and Healthcare products Regulatory Agency (MHRA) has revealed that models of Top-Q dermal filler are being sold with a falsely applied CE Mark.
Aesthetic practitioner national register Save Face has issued a warning as new figures reveal a demand in cosmetic treatments is expected this summer.
The Botulinum Toxin and Cosmetic Fillers (Children) Bill passed its third reading in the House of Lords on April 28.
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979